Skip to content

Program evaluation of GLA:D® Germany: a mixed-methods study using the RE-AIM QuEST framework

Program evaluation of GLA:D® Germany: a mixed-methods study using the RE-AIM QuEST framework

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032853
Enrollment
10000
Registered
2023-10-23
Start date
2022-09-22
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

M16 M17

Interventions

Group 1: Physiotherapists: Participation in a two-day education course in delivering care in accordance with clinical guidelines. Patients: Participation in the GLA:D® program: Two educational ses

Sponsors

Brandenburgische Technische Universität Cottbus-Senftenberg
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Physiotherapists: - Completed professional education Patients: - Diagnosis of hip and/or knee osteoarthritis

Exclusion criteria

Exclusion criteria: None

Design outcomes

Primary

MeasureTime frame
The described study is based on the RE-AIM QuEST framework: (1) Reach: Number of participating physiotherapists and patients (2) Effectiveness: Changes in outcome measures at the individual level of the physiotherapists and patients (3) Adoption: Proportion of institutions that actually initiate the GLA:D® program; proportion of trained physiotherapists that actually initiate the GLA:D® program (4) Implementation: Proportion of education and training sessions perceived by patients (5) Maintenance: Proportion of institutions offering the GLA:D® program over a period of 6 months Overview of data sources and primary outcome assessments: (1) Online survey among physiotherapists Physiotherapists attending the two-day education course will be asked to participate in an online survey. The participants will be asked to fill in the same questionnaire after a period of 1-2 weeks after the course and again after 12 months. Data will be collected in the following categories: 1. Demographic and professional information 2. Current care of patients with hip and/or knee osteoarthritis 3. Beliefs about capabilities related to delivering education and exercise therapy to people with hip and/or knee osteoarthritis The third survey (after 12 months) includes an additional section with open-ended questions on barriers and facilitators to the implementation of GLA:D® Germany. The survey results will be used to investigate the effectiveness of the physiotherapists and to describe barriers and facilitators of the implementation of GLA:D® Germany. (2) National GLA:D®-registry To answer questions about the effectiveness of the intervention with regard to the patients, information from the national GLA:D®-registry is used. This includes results from outcome measurements at the beginning of the GLA:D® program as well as after three and 12 months. Pain intensity (NRS - Numeric Rating Scale), function (KOOS - Knee Injury and Osteoarthritis Outcome Score; HOOS - Hip Disability and

Secondary

MeasureTime frame
In terms of effectiveness at patient level, the following secondary outcomes are considered: - Walking speed (40m Walk Test) - Function (30CST - 30s Chair Stand Test)

Countries

Germany

Contacts

Public ContactChristian Kopkow

Brandenburgische Technische Universität Cottbus-Senftenberg

christian.kopkow@b-tu.de+49 (0) 3573 85 741

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026